compound, prodrug, drug, method for the prophylaxis or treatment of a lower urinary tract symptom, obesity, and / or organ prolapse in a mammal, and, use of the compound.

• 收藏
• 分享

专利权人:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

发明人:

HIRONOBU MAEZAKI,IZUMI NOMURA,SHIGEKAZU SASAKI,TOMOKAZU KUSUMOTO

申请号：

BRPI1011502

公开号：

BRPI1011502A2

申请日:

2010.06.14

申请国别(地区):

BR

年份:

2016

代理人:

摘要：

Provided is a compound having a serotonin 5-HT2C receptor activating action. A compound represented by the formula (I0): wherein each symbol is as defined in the specification, or a salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/